[Disease burden of famale breast cancer in China]
- PMID: 27453107
- DOI: 10.3760/cma.j.issn.0254-6450.2016.07.013
[Disease burden of famale breast cancer in China]
Abstract
Objective: To analyze the data on burden of female breast cancer in China.
Methods: The data from Chinese Cancer Registry Annual Report 2012, three national death cause surveys in China, Disease Surveillance Points system(DSP), China Health Statistics Yearbook, GLOBOCAN 2012, Cancer Incidence in Five Continents(CI5), WHO Mortality Database and Global Burden of Disease(GBD)2013 were used to extract the incidence, mortality and disability-adjusted life years(DALY)of female breast cancer and analyze related trends in China.
Results: The data from three national death cause surveys showed that the crude mortality of breast cancer doubled from year 1973-1975 to year 2004-2005, the increase was higher in urban area(127.4%)than in rural area(75.2%). WHO Mortality Database showed that average annual percentage change(AAPC)of breast cancer crude mortality increased by 3.1%(P<0.05)from 1987 to 2000, and China Health Statistics Yearbook showed that the AAPC in urban females increased by 2.7% from 2002 to 2013(P<0.05), whereas the AAPC in rural females showed no significant change(P>0.05). It was estimated by GLOBOCAN 2012 that in 2012 the age-standardized incidence and age-standardized mortality of breast cancer in China was 22.1 per 100 000 and 5.4 per 100 000, respectively. The age-specific incidence began to increase obviously at age of 40 years and peaked at age 45-59 years(GLOBOCAN 2012). Chinese Cancer Registry Annual Report 2012 showed that breast cancer incidence and mortality were 2-fold and 1.5-fold higher in urban females than in rural females in 2009. It was estimated that the breast cancer case number and death number in females in China would increase to 251 600 and 75 900, respectively, more increose in age group ≥65 years. Only GBD 2013 reported DALY, the DALY caused by breast cancer in China was 1 666.0 thousand in 2013, accounting for 12.7% of global DALY, and increased by 56.7% from 1990(1 062.6 thousand), the peak age-specific DALY rate was at 50 to 59 years, and national average ratio of years lived with disability(YLD)was 8.7%(ranging from 8.1% to 9.0% at provincial level).
Conclusions: Burden of disease caused by female breast cancer is becoming increasingly severe in China, especially in urban areas. It is necessary to strengthen the population-based prevention and control programs and further studies may focus on DALY.
Similar articles
-
[Disease burden and economic burden of breast cancer in females in China: a synthesis analysis].Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Sep 10;45(9):1185-1196. doi: 10.3760/cma.j.cn112338-20240129-00048. Zhonghua Liu Xing Bing Xue Za Zhi. 2024. PMID: 39307690 Chinese.
-
[Disease burden of colorectal cancer in China: any changes in recent years?].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1633-1642. doi: 10.3760/cma.j.cn112338-20200306-00273. Zhonghua Liu Xing Bing Xue Za Zhi. 2020. PMID: 33297619 Chinese.
-
[Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Nov 10;41(11):1848-1858. doi: 10.3760/cma.j.cn112338-20200306-00271. Zhonghua Liu Xing Bing Xue Za Zhi. 2020. PMID: 33297650 Chinese.
-
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries.Asia Pac J Clin Oncol. 2023 Dec;19(6):645-654. doi: 10.1111/ajco.13958. Epub 2023 Apr 7. Asia Pac J Clin Oncol. 2023. PMID: 37026375 Review.
-
Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal.J R Soc Med. 2015 Feb;108(2):57-67. doi: 10.1177/0141076814554671. J R Soc Med. 2015. PMID: 25721114 Free PMC article. Review.
Cited by
-
The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019.Front Oncol. 2024 Jun 20;14:1364397. doi: 10.3389/fonc.2024.1364397. eCollection 2024. Front Oncol. 2024. PMID: 38966067 Free PMC article.
-
Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.Health Qual Life Outcomes. 2019 Oct 15;17(1):153. doi: 10.1186/s12955-019-1224-8. Health Qual Life Outcomes. 2019. PMID: 31615531 Free PMC article.
-
Reproductive Risk Factors Associated with Breast Cancer Molecular Subtypes among Young Women in Northern China.Biomed Res Int. 2020 Apr 6;2020:5931529. doi: 10.1155/2020/5931529. eCollection 2020. Biomed Res Int. 2020. PMID: 32337260 Free PMC article.
-
TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p.Cancer Cell Int. 2019 Mar 29;19:75. doi: 10.1186/s12935-019-0791-4. eCollection 2019. Cancer Cell Int. 2019. Retraction in: Cancer Cell Int. 2024 Apr 5;24(1):128. doi: 10.1186/s12935-024-03310-8. PMID: 30976199 Free PMC article. Retracted.
-
[Digital breast tomosynthesis in diagnosis of dense breast lesions].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Apr 25;48(2):186-192. doi: 10.3785/j.issn.1008-9292.2019.04.10. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31309757 Free PMC article. Chinese.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous